Antipodean Advisors’s Carter's CRI Stock Holding History

Antipodean Advisors’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-692,000	Closed	-$51.3M	–	30
2013 Q2	$51.3M	Buy	+692,000	New	+$46.4M	5.38%	6

Other funds holding CRI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

HCM

Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Antipodean Advisors's CRI Position: Q3 2013 in Review

Antipodean Advisors sold out of Carter's (CRI) in Q3 2013, closing a stake of 692,000 shares — an estimated $51.3M sold.

Antipodean Advisors first reported a position in CRI in Q2 2013 and held it in 1 quarter. The position peaked at $51.3M in Q2 2013. 230 funds tracked by Wall St. Rank hold CRI as of Q3 2013.

Antipodean Advisors reported no remaining Carter's position as of Q3 2013 after selling out during the quarter.
Antipodean Advisors sold 692,000 Carter's shares in Q3 2013, an estimated $51.3M.
Antipodean Advisors first reported a position in Carter's in Q2 2013 and held it in 1 quarter.
Antipodean Advisors's Carter's position peaked at $51.3M in Q2 2013.
230 funds tracked by Wall St. Rank held Carter's as of Q3 2013.

Based on Antipodean Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.